The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Hiroshi Yoshida

Department of Laboratory Medicine

Jikei University Kashiwa Hospital

163-1 Kashiwashita

Kashiwa

Japan

[email]@jikei.ac.jp

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Laboratory Medicine, Jikei University Kashiwa Hospital, 163-1 Kashiwashita, Kashiwa, Japan. 2004 - 2011
  • Division of General Medicine, Department of Internal Medicine, Kashiwa Hospital, Jikei University School of Medicine, Japan. 2005

References

  1. Gender differences in the effects of Angiotensin receptor blockers on cardiovascular disease. Yoshida, H., Rosano, G., Shimizu, M., Mochizuki, S., Yoshimura, M. Curr. Pharm. Des. (2011) [Pubmed]
  2. Sex differences in effects of valsartan administration on cardiovascular outcomes in hypertensive patients: findings from the Jikei Heart Study. Yoshida, H., Shimizu, M., Ikewaki, K., Taniguchi, I., Tada, N., Yoshimura, M., Rosano, G., Dahlöf, B., Mochizuki, S. J. Hypertens. (2010) [Pubmed]
  3. Effects of supervised aerobic exercise training on serum adiponectin and parameters of lipid and glucose metabolism in subjects with moderate dyslipidemia. Yoshida, H., Ishikawa, T., Suto, M., Kurosawa, H., Hirowatari, Y., Ito, K., Yanai, H., Tada, N., Suzuki, M. J. Atheroscler. Thromb. (2010) [Pubmed]
  4. Administration of natural astaxanthin increases serum HDL-cholesterol and adiponectin in subjects with mild hyperlipidemia. Yoshida, H., Yanai, H., Ito, K., Tomono, Y., Koikeda, T., Tsukahara, H., Tada, N. Atherosclerosis (2010) [Pubmed]
  5. Characteristic comparison of triglyceride-rich remnant lipoprotein measurement between a new homogenous assay (RemL-C) and a conventional immunoseparation method (RLP-C). Yoshida, H., Kurosawa, H., Hirowatari, Y., Ogura, Y., Ikewaki, K., Abe, I., Saikawa, S., Domitsu, K., Ito, K., Yanai, H., Tada, N. Lipids. Health. Dis (2008) [Pubmed]
  6. Neuroprotective effects of edaravone: a novel free radical scavenger in cerebrovascular injury. Yoshida, H., Yanai, H., Namiki, Y., Fukatsu-Sasaki, K., Furutani, N., Tada, N. CNS. Drug. Rev (2006) [Pubmed]
  7. Edaravone, a novel radical scavenger, inhibits oxidative modification of low-density lipoprotein (LDL) and reverses oxidized LDL-mediated reduction in the expression of endothelial nitric oxide synthase. Yoshida, H., Sasaki, K., Namiki, Y., Sato, N., Tada, N. Atherosclerosis (2005) [Pubmed]
  8. Implications of decreased serum adiponectin for type IIb hyperlipidaemia and increased cholesterol levels of very-low-density lipoprotein in type II diabetic patients. Yoshida, H., Hirowatari, Y., Kurosawa, H., Tada, N. Clin. Sci. (2005) [Pubmed]
  9. Increased serum iron may contribute to enhanced oxidation of low-density lipoprotein in smokers in part through changes in lipoxygenase and catalase. Yoshida, H., Sasaki, K., Hirowatari, Y., Kurosawa, H., Sato, N., Furutani, N., Tada, N. Clin. Chim. Acta (2004) [Pubmed]
 
WikiGenes - Universities